Skip to main content
. 2019 Feb 13;13(8):963–969. doi: 10.1093/ecco-jcc/jjz041

Table 3.

Median vedolizumab concentrations and corticosteroid-free endoscopic remission

Median vedolizumab concentration, µg/mL [IQR]
IBD [p = 0.003]
Remission [n = 30] 14.2 [8.4–21.2]
No remission [n = 53] 8.5 [5.5–13.8]
UC [p = 0.26]
Remission [n = 10] 11.3 [8.8–21.2]
No remission [n = 18] 9.75 [5.5–13.8]
CD [p = 0.008]
Remission [n = 20] 15.0 [8.3–20.7]
No remission [n = 35] 7.5 [5.0–13.8]

Abbreviations: IBD, inflammatory bowel disease; UC, ulcerative colitis; CD: Crohn’s disease; IQR, interquartile range.